000303255 001__ 303255
000303255 005__ 20250802114338.0
000303255 0247_ $$2doi$$a10.1002/1873-3468.70114
000303255 0247_ $$2pmid$$apmid:40741889
000303255 0247_ $$2ISSN$$a0014-5793
000303255 0247_ $$2ISSN$$a1873-3468
000303255 037__ $$aDKFZ-2025-01600
000303255 041__ $$aEnglish
000303255 082__ $$a610
000303255 1001_ $$aFaria, Carla$$b0
000303255 245__ $$aGoodbye flat lymphoma biology.
000303255 260__ $$aChichester$$bWiley$$c2025
000303255 3367_ $$2DRIVER$$aarticle
000303255 3367_ $$2DataCite$$aOutput Types/Journal article
000303255 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1754056281_19093$$xReview Article
000303255 3367_ $$2BibTeX$$aARTICLE
000303255 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000303255 3367_ $$00$$2EndNote$$aJournal Article
000303255 500__ $$a#EA:B060# / epub
000303255 520__ $$aB-cell lymphomas grow in aggregates, closely interacting with specific physical elements and cellular environments. While 2D culture systems have long been the standard in the field, current methodologies aim to better replicate lymphoma biology and its microenvironment in 3D. Significant progress has been made since the first 3D lymphoma cell line culture was developed in 2012. Subsequent advances in both cell line and patient-derived systems have incorporated key physical and cellular microenvironmental components. This Review compiles the relevant 3D non-Hodgkin lymphoma models available, outlining their main features, strengths, and limitations. Additionally, we highlight the critical gaps that must be addressed to develop robust, multiplexed, patient-derived B-cell lymphoma systems, which can serve as reliable avatars alongside clinical trials and contribute to the principles of the 3Rs in animal research. Impact statement In the last few years new B-cell lymphoma 3D models have emerged, with a special emphasis on patient-derived models. These systems are fundamental tools for precision medicine. This review provides translational researchers and clinician scientists with an excellent overview of these novel tools with their strong and weak points.
000303255 536__ $$0G:(DE-HGF)POF4-312$$a312 - Funktionelle und strukturelle Genomforschung (POF4-312)$$cPOF4-312$$fPOF IV$$x0
000303255 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000303255 650_7 $$2Other$$adiffuse large B‐cell lymphoma
000303255 650_7 $$2Other$$afollicular lymphoma
000303255 650_7 $$2Other$$alymphoma‐on‐chip
000303255 650_7 $$2Other$$amantle cell lymphoma
000303255 650_7 $$2Other$$anon‐Hodgkin lymphoma
000303255 650_7 $$2Other$$apatient‐derived lymphoma models
000303255 650_7 $$2Other$$apreclinical 3D models
000303255 7001_ $$0P:(DE-He78)07639d1e213099020e35bd19f159a705$$aDobano-Lopez, Celia$$b1$$eFirst author$$udkfz
000303255 7001_ $$00000-0003-3895-5024$$aPérez-Galán, Patricia$$b2
000303255 7001_ $$aBezombes, Christine$$b3
000303255 773__ $$0PERI:(DE-600)1460391-3$$a10.1002/1873-3468.70114$$gp. 1873-3468.70114$$pnn$$tFEBS letters$$vnn$$x0014-5793$$y2025
000303255 909CO $$ooai:inrepo02.dkfz.de:303255$$pVDB
000303255 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)07639d1e213099020e35bd19f159a705$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000303255 9131_ $$0G:(DE-HGF)POF4-312$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vFunktionelle und strukturelle Genomforschung$$x0
000303255 9141_ $$y2025
000303255 915__ $$0StatID:(DE-HGF)3001$$2StatID$$aDEAL Wiley$$d2024-12-19$$wger
000303255 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFEBS LETT : 2022$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-19
000303255 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-19
000303255 9201_ $$0I:(DE-He78)B060-20160331$$kB060$$lB060 Molekulare Genetik$$x0
000303255 980__ $$ajournal
000303255 980__ $$aVDB
000303255 980__ $$aI:(DE-He78)B060-20160331
000303255 980__ $$aUNRESTRICTED